Profile | GDS2987 / GI_28376663-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 15 | 46 |
GSM215244 | HMVEC_vehicle_rep2 | 48.2 | 68 |
GSM215253 | HMVEC_vehicle_rep3 | 15.7 | 46 |
GSM215254 | HMVEC_atorvastatin_rep1 | 9.3 | 25 |
GSM215282 | HMVEC_atorvastatin_rep3 | 1 | 2 |
GSM215344 | HMVEC_atorvastatin_rep2 | 9.2 | 23 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 2.2 | 4 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 8.6 | 18 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 35.2 | 50 |
GSM215294 | HMVEC_SLx2119_rep1 | 13.7 | 44 |
GSM215295 | HMVEC_SLx2119_rep2 | 0.7 | 1 |
GSM215296 | HMVEC_SLx2119_rep3 | 19.9 | 32 |
GSM215297 | PASMC_vehicle_rep1 | 26.7 | 39 |
GSM215298 | PASMC_vehicle_rep2 | 42.3 | 54 |
GSM215310 | PASMC_vehicle_rep3 | 47.6 | 59 |
GSM215311 | PASMC_atorvastatin_rep1 | 31 | 48 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | 46.7 | 56 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 32.3 | 48 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 33.1 | 53 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 4.2 | 7 |
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | 38 | 55 |
GSM215329 | PASMC_SLx2119_rep3 | 38.6 | 57 |
GSM215330 | Fibroblasts_vehicle_rep1 | 40.9 | 63 |
GSM215331 | Fibroblasts_vehicle_rep2 | 34.7 | 62 |
GSM215332 | Fibroblasts_vehicle_rep3 | 11.4 | 36 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 25.2 | 54 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 17.7 | 44 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 19 | 43 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 7.3 | 24 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 21 | 54 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 17.6 | 44 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 44.6 | 68 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 14.5 | 38 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 26.1 | 53 |